Advertisement
The widely prescribed drug pregabalin (Lyrica) may slightly increase the risk for birth defects

Pregabalin in Pregnancy Linked to Increased Risk of Birth Defects

0
Defects include cardiac defects, structural anomalies in the central nervous system or other organs
Strategies can be employed to maximize the amount of time available for patient care by streamlining revenue-related processes

Strategies Can Help Streamline Revenue-Related Processes

0
They can be employed to help maximize amount of time available for patient care
Use of pembrolizumab (Keytruda) in advanced melanoma is extending survival for many and even curing some

ASCO: Pembrolizumab Improves Survival in Melanoma

0
Three-year overall survival rate of 40 percent; median overall survival of 24.4 months
The U.S. Food and Drug Administration has approved atezolizumab (Tecentriq)

FDA Approves Tecentriq to Treat Urothelial Carcinoma

0
FDA also approves a companion test to detect PD-L1 protein expression levels in patients
Nocturnal hypoglycemia frequently occurs in children with type 1 diabetes

Nocturnal Hypoglycemia Often Occurs in Children With T1DM

0
Low bedtime glucose, daytime physical activity increase risk of nocturnal hypoglycemia
Men with localized prostate cancer often have unrealistic survival expectations

Unrealistic Expectations for Many Men With Localized Prostate CA

0
Most patients underestimate life expectancy without treatment, overestimate gains of tx
For patients receiving an everolimus-eluting stent implantation

Adverse Events Not Up With Six Months of DAPT

0
Comparable results for 12-month DAPT among patients receiving everolimus-eluting stents
Skeletal muscle TRIB3 mediates glucose-induced insulin resistance in a mouse model of diabetes

Skeletal Muscle TRIB3 Mediates Diet-Induced Insulin Resistance

0
TRIB3 overexpressing mice have greater weight gain, worse insulin resistance in response to high-fat diet
Prophylactic early high-dose recombinant human erythropoietin given intravenously to very preterm infants does not improve neurodevelopmental outcomes at 2 years corrected age

Prophylactic High-Dose rhEPO No Benefit for Preemies

0
No difference in Mental Development Index compared with placebo at 2 years corrected age
While powerful HIV medications are allowing patients to live longer

Cancer Treatment Lacking for HIV-Infected Patients

0
But it's not clear what's driving the difference in care, researcher says